Why Biocore
Building regulatory data infrastructure in-house, relying on openFDA, or scraping agency sites each carries real cost and risk. Here is how Biocore compares.
Biocore vs. Building In-House
Time to coverage
Building a regulatory data pipeline from scratch takes 6–18 months before it delivers reliable, production-ready data. Biocore provides that coverage on day one through a single API.
Maintenance
Each regulatory source — FDA, EMA, PMDA and others — changes its format and schema independently, so an in-house pipeline needs continuous engineering to avoid silent breakage. Biocore absorbs that maintenance burden.
Coverage
Achieving eight-jurisdiction coverage in-house means monitoring 17+ sources, each in a different format and language. Biocore delivers all eight jurisdictions normalized into one consistent schema.
Cost
In-house regulatory data requires dedicated engineering and regulatory-affairs headcount across build, ongoing maintenance, and compliance validation. Biocore replaces that standing cost with a single managed subscription.
Biocore vs. openFDA / Manual Monitoring
The openFDA gap
openFDA provides raw FDA data with no normalization, no multi-jurisdiction coverage, and no service-level agreement. Biocore adds normalization, eight jurisdictions, webhooks, and an SLA suited to production systems.
Scraping risk
Scraping regulatory sources directly introduces legal risk, ongoing maintenance burden, and no guarantee of structural consistency when pages change. Biocore licenses and normalizes the data so your integration stays stable.
Latency
Manual monitoring introduces 24–72 hour delays between a regulatory change and your team noticing it. Biocore ingests updates within 24 hours and dispatches webhooks within hours of any change.
Scale
Manual processes break down when tracking updates across many products and jurisdictions at once. Biocore scales to every product and jurisdiction through one API without adding headcount.
Build vs. Buy FAQ
The alternative is licensing normalized regulatory data through an API like Biocore. Instead of spending 6–18 months building ingestion for 17+ sources and maintaining it indefinitely, you consume one normalized schema across eight jurisdictions immediately, redirecting engineering effort toward your actual product.
openFDA offers raw, FDA-only data through a public API with no normalization, multi-jurisdiction coverage, or service-level guarantee. Biocore covers eight jurisdictions in one normalized schema, adds webhooks for real-time change notification, and provides an SLA, making it suited to production systems rather than exploratory queries.
Scraping regulatory sources directly introduces legal risk, constant maintenance as pages change, and no guarantee that data structure stays consistent. Biocore licenses and normalizes the data into a stable schema, so your integration keeps working without rework every time an agency changes its website.
Building in-house carries standing costs across engineering and regulatory-affairs headcount for the initial build, continuous maintenance as 17+ sources change formats, and compliance validation. Biocore replaces those recurring personnel and infrastructure costs with a single managed subscription priced per engagement.
Building reliable multi-jurisdiction coverage in-house typically takes 6–18 months before the pipeline is production-ready, and longer to reach all eight jurisdictions. Biocore delivers that coverage immediately, so teams reach production in minutes rather than waiting through a multi-quarter build.
Building carries risks of schema drift, silent data breakage, missed regulatory updates, and validation gaps, all requiring dedicated staff. Buying through Biocore shifts those risks to managed infrastructure with normalization, monitoring, webhooks, and audit-ready data, while your team retains control of how the data is used.
Pharmaceutical and health-technology engineering teams, compliance and pharmacovigilance groups, and AI product teams use Biocore instead of building in-house. They share a need for accurate, normalized, multi-jurisdiction regulatory data without dedicating engineers to perpetually maintaining ingestion pipelines across changing agency sources.
Biocore replaces the data-engineering and source-monitoring burden a regulatory affairs team would otherwise carry, delivering normalized, audit-ready data automatically. It does not replace regulatory judgment or strategy; instead it frees regulatory affairs staff to focus on interpretation and decisions rather than collecting and reconciling raw data.
Skip the 6–18 month build
Get normalized regulatory data across eight jurisdictions through one API.